Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-16-150568

Chief Scientific Officer sold 32,500 shares at $65.00 ($2,112,500)

  • Chief Scientific Officer acquired 27,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Biller Scott · Chief Scientific Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2016-11-14 Sale : show line 1 in the form −5,000 $65.00 $325,000 6,000 I
2016-11-14 Exercise or conversion : show line 2 in the form +6,889 $0.47 $3,221 55,159 D
2016-11-14 Exercise or conversion : show line 3 in the form +14,091 $9.05 $127,524 69,250 D
2016-11-14 Exercise or conversion : show line 4 in the form +6,520 $31.64 $206,293 75,770 D
2016-11-14 Sale : show line 5 in the form −27,500 $65.00 $1,787,500 48,270 D
Open-market sales · 32,500 sh · avg $65.00 · $2,112,500

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2016-11-14 Exercise or conversion : show line 6 in the form Stock option (right to buy) −6,889 5,474 D
2016-11-14 Exercise or conversion : show line 7 in the form Stock option (right to buy) −14,091 20,000 D
2016-11-14 Exercise or conversion : show line 8 in the form Stock option (right to buy) −6,520 35,286 D
Loading xslF345X03/doc4.xml…